159 related articles for article (PubMed ID: 24151402)
21. Diffuse large B-cell lymphoma of the prostate.
Warrick JI; Owens SR; Tomlins SA
Arch Pathol Lab Med; 2014 Oct; 138(10):1286-9. PubMed ID: 25268190
[TBL] [Abstract][Full Text] [Related]
22. Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era.
Yang DH; Ahn JS; Byun BH; Min JJ; Kweon SS; Chae YS; Sohn SK; Lee SW; Kim HW; Jung SH; Kim YK; Kim HJ; Bom HS; Lee JJ
Ann Hematol; 2013 Apr; 92(4):471-9. PubMed ID: 23238895
[TBL] [Abstract][Full Text] [Related]
23. [18F]fluorodeoxyglucose positron emission tomography predicts survival after chemoimmunotherapy for primary mediastinal large B-cell lymphoma: results of the International Extranodal Lymphoma Study Group IELSG-26 Study.
Martelli M; Ceriani L; Zucca E; Zinzani PL; Ferreri AJ; Vitolo U; Stelitano C; Brusamolino E; Cabras MG; Rigacci L; Balzarotti M; Salvi F; Montoto S; Lopez-Guillermo A; Finolezzi E; Pileri SA; Davies A; Cavalli F; Giovanella L; Johnson PW
J Clin Oncol; 2014 Jun; 32(17):1769-75. PubMed ID: 24799481
[TBL] [Abstract][Full Text] [Related]
24. Using 18F-FDG positron emission tomography/computed tomography to judge benign or malignant colorectal hypermetabolic lesions.
Li W; Fan W
Chin J Cancer; 2010 Mar; 29(3):306-11. PubMed ID: 20193115
[TBL] [Abstract][Full Text] [Related]
25. Intravascular large B-cell lymphoma diagnosed by FDG-PET/CT and endometrial biopsy.
Takeoka Y; Inaba A; Fujitani Y; Kosaka S; Yamamura R; Senzaki H; Okamura T; Ohta K
Rinsho Ketsueki; 2011 Nov; 52(11):1777-81. PubMed ID: 22185801
[TBL] [Abstract][Full Text] [Related]
26. 18F-fluoro-2-deoxy-D-glucose positron emission tomography/computed tomography in the diagnosis and follow-up of primary hepatic diffuse large B-cell Lymphoma: A clinical case report.
Wang L; Dong P; Hu W; Tian B
Medicine (Baltimore); 2020 Jan; 99(5):e18980. PubMed ID: 32000430
[TBL] [Abstract][Full Text] [Related]
27. Utility of the PET-CT in the evaluation of early response to treatment in the diffuse large B-cell lymphoma. Preliminary results.
Cortés Romera M; Gámez Cenzano C; Caresia Aróztegui AP; Martín-Comín J; González-Barca E; Ricart Brulles Y; Palacios Abufón A; Robles Barba J; Rodríguez-Bel L; Rossi Seoane S; Fernández de Sevilla A
Rev Esp Med Nucl Imagen Mol; 2012; 31(3):135-41. PubMed ID: 21944191
[TBL] [Abstract][Full Text] [Related]
28. FDG-PET/CT is a pivotal imaging modality to diagnose rare intravascular large B-cell lymphoma: case report and review of literature.
Colavolpe C; Ebbo M; Trousse D; Khibri H; Franques J; Chetaille B; Coso D; Ouvrier MJ; Gastaud L; Guedj E; Schleinitz N
Hematol Oncol; 2015 Jun; 33(2):99-109. PubMed ID: 24850057
[TBL] [Abstract][Full Text] [Related]
29. The impact of R-VACOP-B and interim FDG-PET/CT on outcome in primary mediastinal large B cell lymphoma.
Avigdor A; Sirotkin T; Kedmi M; Ribakovsy E; Berkowicz M; Davidovitz Y; Kneller A; Merkel D; Volchek Y; Davidson T; Goshen E; Apter S; Shimoni A; Ben-Bassat I; Nagler A
Ann Hematol; 2014 Aug; 93(8):1297-304. PubMed ID: 24595734
[TBL] [Abstract][Full Text] [Related]
30. MRI, enhanced CT, and FDG PET/CT in basal cell carcinoma of the prostate.
Dong A; Zuo C; Lu J; Wang Y
Clin Nucl Med; 2014 Aug; 39(8):721-4. PubMed ID: 24152659
[TBL] [Abstract][Full Text] [Related]
31. Are we ready for positron emission tomography/computed tomography-based target volume definition in lymphoma radiation therapy?
Yeoh KW; Mikhaeel NG
Int J Radiat Oncol Biol Phys; 2013 Jan; 85(1):14-20. PubMed ID: 22578540
[TBL] [Abstract][Full Text] [Related]
32. Incidental diagnosis of diffuse large B-cell lymphoma by 11C-choline PET/CT in a patient with biochemical recurrence of prostate cancer.
Garzon JG; Bassa P; Moragas M; Soler M; Riera E
Clin Nucl Med; 2014 Aug; 39(8):742-3. PubMed ID: 24978327
[TBL] [Abstract][Full Text] [Related]
33. Residual Anatomical Disease in Diffuse Large B-Cell Lymphoma Patients With FDG-PET-Based Complete Response After First-Line R-CHOP Therapy: Does It Have Any Prognostic Value?
Adams HJ; de Klerk JM; Fijnheer R; Heggelman BG; Dubois SV; Nievelstein RA; Kwee TC
J Comput Assist Tomogr; 2015; 39(5):810-5. PubMed ID: 26035406
[TBL] [Abstract][Full Text] [Related]
34. Utilization of 18F-FDG PET/CT as a staging tool in patients with newly diagnosed lymphoma.
Cho SF; Chang CC; Liu YC; Chang CS; Hsiao HH; Liu TC; Huang CT; Lin SF
Kaohsiung J Med Sci; 2015 Mar; 31(3):130-7. PubMed ID: 25744235
[TBL] [Abstract][Full Text] [Related]
35. Computed tomography and 18F-FDG positron emission tomography for therapy control of Hodgkin's and non-Hodgkin's lymphoma patients: when do we really need FDG-PET?
Reinhardt MJ; Herkel C; Altehoefer C; Finke J; Moser E
Ann Oncol; 2005 Sep; 16(9):1524-9. PubMed ID: 15946979
[TBL] [Abstract][Full Text] [Related]
36. Interim18 F-FLUORO-2-deoxy-d-glucose positron emission tomography scan/computed tomography scan in diffuse large B cell lymphoma-as a prognostic tool.
Basit A; Siddiqui N; Muzaffar N; Awan UK; Bashir H; Khan SA; Hameed A
J Pak Med Assoc; 2016 Apr; 66(4):380-6. PubMed ID: 27122261
[TBL] [Abstract][Full Text] [Related]
37. 18F-Choline and 18F-FDG PET/CT in a Patient With Diffuse Large B-Cell Lymphoma and Recurrent Prostate Cancer.
De Leiris N; Riou L; Leenhardt J; Vuillez JP; Djaileb L
Clin Nucl Med; 2018 Dec; 43(12):e471-e472. PubMed ID: 30300202
[TBL] [Abstract][Full Text] [Related]
38. Diffuse pulmonary uptake on FDG-PET with normal CT diagnosed as intravascular large B-cell lymphoma: a case report and a discussion of the causes of diffuse FDG uptake in the lungs.
Wagner T; Brechemier D; Dugert E; Le Guellec S; Julian A; Hitzel A; Beyne-Rauzy O
Cancer Imaging; 2012 Jan; 12(1):7-12. PubMed ID: 22275725
[TBL] [Abstract][Full Text] [Related]
39. Pulmonary intravascular lymphoma detected by FDG PET-CT: a case report.
Kohan AA; Paganini L; Biedak P; Arma JI; Dalurzo MC; Garcia-Monaco RD
Rev Esp Med Nucl Imagen Mol; 2013; 32(5):318-20. PubMed ID: 23317519
[TBL] [Abstract][Full Text] [Related]
40. Predictive value of interim ¹⁸F-FDG-PET/CT for event-free survival in patients with diffuse large B-cell lymphoma homogenously treated in a phase II trial with six cycles of R-CHOP-14 plus pegfilgrastim as first-line treatment.
González-Barca E; Canales M; Cortés M; Vidal MJ; Salar A; Oriol A; Bargay J; Bello JL; Sánchez JJ; Tomás JF; Donato E; Ferrer S; Caballero D;
Nucl Med Commun; 2013 Oct; 34(10):946-52. PubMed ID: 23880897
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
